Recruiting

Hydrolyzed Whey for Cholesterol Management in Adults

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Standard whey

+ Hydrolyzed whey

Dietary Supplement
Who is being recruted

Inflammation

+ Pathologic Processes

+ Pathological Conditions, Signs and Symptoms

From 21 to 59 Years
+18 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Prevention Study

Placebo-Controlled
Interventional
Study Start: August 2025
See protocol details

Summary

Principal SponsorMedinutra LLC
Study ContactRobert DiSilvestro, Ph.D.
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: August 5, 2025

Actual date on which the first participant was enrolled.

This study explores the potential benefits of hydrolyzed whey protein for managing cholesterol levels in adults aged 21 to 59. Many people within this age group have borderline high cholesterol and do not use medication to manage it. The aim is to see if a specific type of whey protein can help lower cholesterol levels directly, which could be a safe and cost-effective alternative to medications. This research might also show if hydrolyzed whey can reduce low-level inflammation, which is linked to several long-term health problems. Participants will consume either hydrolyzed whey protein or whey protein isolate daily for six weeks. The study is designed to be double-blind, meaning neither the participants nor the researchers will know which protein each participant is consuming. Blood samples will be taken before and after the six-week period to measure changes in cholesterol levels and inflammation markers. The study aims to determine if there is a significant change in these health markers, with safety considerations primarily focusing on potential allergies to whey protein. Participants with known milk allergies will not be eligible to join.

Official TitleHydrolyzed Whey for Blood Lipid Control
NCT07101263
Principal SponsorMedinutra LLC
Study ContactRobert DiSilvestro, Ph.D.
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

72 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Prevention Study

Prevention studies aim to stop a disease from developing. They often involve people at risk and test things like vaccines, lifestyle changes, or preventive medications.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 21 to 59 Years

Range of ages for which participants are eligible to join.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

InflammationPathologic ProcessesPathological Conditions, Signs and Symptoms

Criteria

2 inclusion criteria required to participate
Cholesterol reading of 190 to 225 mg/dL

Age 21-59 years old

16 exclusion criteria prevent from participating
Uncontrolled diabetes

Hypothyroidism or other hormonal problems that have not stabilized

Any liver diseases being actively treated

Cancer

Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

2 intervention groups are designated in this study

50% chance of being blinded to the placebo group

Treatment Groups

Group I

Placebo
A standard whey protein is consumed daily for 6 weeks

Group II

Experimental
A hydrolyzed whey protein is consumed daily for 6 weeks

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Recruiting

Medinutra LLC

Dublin, United StatesOpen Medinutra LLC in Google Maps
Recruiting
One Study Center